IL80032A - Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them - Google Patents

Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL80032A
IL80032A IL80032A IL8003286A IL80032A IL 80032 A IL80032 A IL 80032A IL 80032 A IL80032 A IL 80032A IL 8003286 A IL8003286 A IL 8003286A IL 80032 A IL80032 A IL 80032A
Authority
IL
Israel
Prior art keywords
aminocarbonylsulfonamides
tumor
phenyl
preparation
pharmaceutical compositions
Prior art date
Application number
IL80032A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL80032A publication Critical patent/IL80032A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL80032A 1985-09-23 1986-09-15 Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them IL80032A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US88867586A 1986-07-24 1986-07-24

Publications (1)

Publication Number Publication Date
IL80032A true IL80032A (en) 1992-07-15

Family

ID=27119572

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80032A IL80032A (en) 1985-09-23 1986-09-15 Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0222475B1 (fr)
JP (1) JPH0662548B2 (fr)
KR (1) KR880000204B1 (fr)
CN (1) CN1013198B (fr)
AU (1) AU587064B2 (fr)
CY (1) CY1659A (fr)
DE (1) DE3667168D1 (fr)
DK (1) DK160981C (fr)
EG (1) EG18046A (fr)
ES (1) ES2001698A6 (fr)
GR (1) GR862353B (fr)
HK (1) HK88692A (fr)
HU (1) HU200597B (fr)
IE (1) IE59588B1 (fr)
IL (1) IL80032A (fr)
MX (1) MX9203126A (fr)
NZ (1) NZ217597A (fr)
PT (1) PT83389B (fr)
SG (1) SG66892G (fr)
SU (1) SU1545939A3 (fr)
UA (1) UA5953A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
CA1331464C (fr) * 1987-05-12 1994-08-16 Eli Lilly And Company Methode et composes antitumoraux
HU202487B (en) * 1988-03-04 1991-03-28 Mta Koezponti Kemiai Kutato In Process for producing n-sulfonylureas
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (fr) * 1992-12-10 1994-06-11 Gerald Burr Grindey Compositions antitumorales et methodes de traitement
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5976401A (en) * 1996-08-07 1999-11-02 Tomita Pharmaceutical Co., Ltd. Agent for removing phosphates, nitrates and nitrites from wastewater
EP1021437B1 (fr) * 1996-08-22 2001-11-14 Dong Wha Pharmaceutical Industrial Co. Ltd. Derives d'arylsulfonylimidazoline agissant en tant qu'agents anti-tumoraux
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
EP2364699A1 (fr) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Utilisation conjointe d'un composé à base de sulfonamide avec un inhibiteur de l'angiogénèse
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
WO2006090927A1 (fr) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. Action orexigenique d'un compose de sulfonamide
WO2006090930A1 (fr) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. Nouvelle utilisation combinee d'un compose de sulfonamide
AU2006217690B2 (en) * 2005-02-28 2012-03-15 Eisai R & D Management Co., Ltd. Novel use of sulfonamide compound in combination with angiogenesis inhibitor
WO2007123274A1 (fr) 2006-04-20 2007-11-01 Eisai R & D Management Co., Ltd. Nouveau marqueur CONTRE la SENSIBILITÉ À un COMPOSÉ de sulfonamide
JP2012136435A (ja) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd 腫瘍組織の感受性を検査する方法
CN102993106B (zh) * 2012-12-24 2015-06-17 武汉武药制药有限公司 格列吡嗪的合成新路线
GB201618240D0 (en) * 2016-10-27 2016-12-14 Trade Vehicle Locks Ltd Apparatus for locking a door of a vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides

Also Published As

Publication number Publication date
DE3667168D1 (de) 1990-01-04
CY1659A (en) 1993-05-14
PT83389B (pt) 1989-05-12
GR862353B (en) 1987-01-19
IE862503L (en) 1987-03-23
AU6294286A (en) 1987-03-26
KR870003086A (ko) 1987-04-15
EP0222475A1 (fr) 1987-05-20
HUT46657A (en) 1988-11-28
ES2001698A6 (es) 1988-06-01
DK160981C (da) 1991-10-28
IE59588B1 (en) 1994-03-09
UA5953A1 (uk) 1994-12-29
DK446986D0 (da) 1986-09-18
DK446986A (da) 1987-03-24
SU1545939A3 (ru) 1990-02-23
JPH0662548B2 (ja) 1994-08-17
CN86106428A (zh) 1987-03-18
DK160981B (da) 1991-05-13
MX9203126A (es) 1992-07-01
EP0222475B1 (fr) 1989-11-29
NZ217597A (en) 1989-06-28
HU200597B (en) 1990-07-28
HK88692A (en) 1992-11-20
EG18046A (en) 1991-08-30
AU587064B2 (en) 1989-08-03
CN1013198B (zh) 1991-07-17
PT83389A (en) 1986-10-01
JPS6296459A (ja) 1987-05-02
KR880000204B1 (ko) 1988-03-12
SG66892G (en) 1992-09-04

Similar Documents

Publication Publication Date Title
IL79323A0 (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IL80296A (en) Phenylpyridone derivatives,their preparation and pharmaceutical compositions containing them
IL80032A (en) Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
IL78079A0 (en) Sulphonylaminoethyl compounds,their preparation and pharmaceutical compositions containing them
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL84875A0 (en) 8-substituted 2-aminotetralins,their preparation and pharmaceutical compositions containing them
IL78643A0 (en) Purine derivatives,their preparation and pharmaceutical compositions containing them
IL79266A (en) Aralkylpiperidinylbenzyl alcohols,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL78804A (en) N-benzhydrylpiperazinealkananilides,their preparation and pharmaceutical antianaphylactic and antibronchospastic compositions containing them
IL84302A (en) Substituted :-aminoacids, their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL79402A0 (en) Poly-4-aminopyrrole-2-carboxamido derivatives,their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL79247A0 (en) Saccharides,their preparation and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
IL80824A0 (en) Tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL84509A0 (en) Pyrrolo-benzimidazoles,their preparation and pharmaceutical composition containing them
IL79234A0 (en) Pyridazodiazepine phosphates,their preparation and pharmaceutical compositions containing them
IL84633A0 (en) 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them
IL77614A (en) Interfuranylene-prostacyclin derivatives,their preparation and pharmaceutical compositions containing them
IL78687A0 (en) Acylaminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
IL80379A0 (en) Gonadoliberine analogues,their preparation and pharmaceutical compositions containing them
IL78963A0 (en) N-phenyl-1-piperazine carboxamidines and related compounds,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees